Skip to main content

Search This Blog

Flourishing Capital

Posts

Showing posts from December, 2022

Flourishing Capital invests in ambitious private and public companies. Our Health Fund invests in biotech and pharmaceutical companies pursuing novel therapies and treatments with tremendous commercial potential. Subscribe to newsletter to learn more.

Powered by Blogger

© Flourishing Capital. All Rights Reserved.

Report Abuse

© 2024 Flourishing Capital. All Rights Reserved. Disclosures: The author has no business relationship with any company whose stock is mentioned in this article. The author may have a stock, option and similar derivative position(s) in companies and the investment ideas discussed herein. Information presented herein is offered as educational and informational materials to assist investors in performing due diligence. Investing in stocks and options can result in a loss of capital, and investors should perform their own due diligence and consult with a registered financial advisor for specific guidance. Any projections, market outlooks or estimates herein are forward looking statements and are based upon certain assumptions and should not be construed to be indicative of actual events that will occur. This article is an opinion written at a point in time by the author. The data in this article were obtained from public sources believed to be reliable, but their accuracy and completeness are not guaranteed. The author expressly disclaims all liability for errors and omissions in the service and for the use or interpretation by others of information contained herein. Any and all opinions, estimates, and conclusions are based on the author's best judgment at the time of publication, and are subject to change without notice. The author undertakes no obligation to correct, update or revise the information in this document or to otherwise provide any additional materials. The author's opinions expressed herein address only a small cross-section of data related to an investment in securities mentioned. Any analysis presented is based on incomplete information, and is limited in scope and accuracy. Past performance is no guarantee of future returns.

Flourishing Capital: Flourishing Capital invests in ambitious private and public biotech and pharmaceutical companies pursuing novel therapies and treatments with tremendous commercial potential. Our Chief Investment Officer has 30 years of experience in finance and leadership. He earned MBA with a concentration in Finance and Entrepreneurship from the University of Maryland and a BS/BA with concentrations in Management, Finance, and Entrepreneurship from the University of Richmond. He was a 2023 recipient of the Charles A. Sanders MD, Partnership Award by the Foundation for the National Institutes of Health. https://bit.ly/FNIH_Award His career experience includes working as a CFO for a technology services company, in big four accounting for Arthur Andersen and KPMG, and in public company corporate finance and investor relations at the CoStar Group (NASDAQ: CSGP) and America Online (NYSE: AOL) Please review my comprehensive disclosures.

Contact Us

Name

Email *

Message *

Archive

December 20221